Search - tctmd.com

Presenter: Nienke van Ditzhuijzen, Oana Sorop, Mieke van den Heuvel, Jurgen M.R. Ligthart, Karen T. Witberg, Richard van Duin, Ilona Krabbendam-Peters, Douglas Follett, Nagarajan Ramesh, Richard Rapoza, Dirk J. Duncker, Evelyn Regar, Heleen M.M. van Beusekom, Hector M. Garcia-Garcia, Wim J. van der Giessen

January 03, 2012

Presentation TCT 2012

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Presenter: John Ormiston, William Wijns, Charlene Knape, Mathias Vrolix, James Stewart, Mark Webster, Robert Whitbourn, Alexandra Lansky, Hiram Bezzera, Peter Fitzgerald, David Kandzari

January 03, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

November 02, 2011

Advertisement

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

From ABSORB Cohort A to ABSORB III and IV Randomized Trials

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

Se elabora un Plan de Acción para Optimizar la Seguridad de la Radiación de las Imágenes Cardiovasculares

Action Plan to Optimize Radiation Safety of Cardiovascular Imaging Developed

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

La Definición Universal de IM se Posiciona en Favor del Cangrelor en las PCI

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Abbott to Present New Data for Key Vascular Products at TCT 2011

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content